data
query
queries
{
"author": {
"name": "Anna Edney",
"webUrl": "/author/profile/anna-edney/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 133,
"social": [],
"articles": [
{
"uri": "/2023/06/26/gsk-settles-first-zantac-cancer-lawsuit-pfizer-and-sanofi-settled-previously/",
"title": "GSK settles first Zantac cancer lawsuit (Pfizer and Sanofi settled previously)",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "June 26, 2023",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/06/Zantac-Article-202306260847.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "More than 70,000 Zantac lawsuits have been filed against the drugmaker and the other pharmaceutical companies, including Pfizer and Sanofi, that sold the heartburn drug.",
"body": null
},
{
"uri": "/2019/07/24/senate-bill-would-tie-drug-costs-to-inflation/",
"title": "Senate bill would tie drug costs to inflation",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "July 24, 2019",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/05/PillsCoinsShutterstock.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The latest attempt to curb drug prices would penalize pharmaceutical companies for raising prices faster than the rate of inflation.",
"body": null
},
{
"uri": "/2019/05/08/hhs-finalizes-rule-requiring-drug-price-disclosures-in-tv-ads/",
"title": "HHS finalizes rule requiring drug price disclosures in TV ads",
"byline": "Anna Edney",
"kicker": "News",
"prettyDate": "May 08, 2019",
"timeToRead": "2 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/01/TvViewers.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Drugmakers will have to disclose a drug's cost if its price before rebates and discounts is above $35 for a month's supply.",
"body": null
},
{
"uri": "/2019/05/03/cbo-curbing-drug-rebates-would-cost-billiions/",
"title": "CBO: Curbing drug rebates would cost billions",
"byline": "Anna Edney",
"kicker": "Analysis",
"prettyDate": "May 03, 2019",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/12/DrugPriceFixing.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/analysis/",
"sectionName": "Analysis"
}
],
"summary": "A proposal to end drug rebates in Medicare would increase spending by about $170 billion over 10 years, CBO says.",
"body": null
},
{
"uri": "/2019/05/01/cbo-medicare-for-all-a-major-undertaking/",
"title": "CBO: Medicare for All a 'major undertaking'",
"byline": "Anna Edney and John Tozzi",
"kicker": "Analysis",
"prettyDate": "May 01, 2019",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/GavelFlagMedicare-1.jpg",
"width": "600",
"height": "398"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/john-tozzi/",
"name": "John Tozzi"
}
],
"kickerNode": [
{
"uri": "/analysis/",
"sectionName": "Analysis"
}
],
"summary": "The report is likely to give both opponents and supporters of Medicare for All ammunition.",
"body": null
},
{
"uri": "/2019/04/12/drugmakers-cave-on-insulin-prices-why-now/",
"title": "Drugmakers cave on insulin prices. Why now?",
"byline": "Cynthia Koons and Anna Edney",
"kicker": "News",
"prettyDate": "April 12, 2019",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/11/Diabetic.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/cynthia-koons/",
"name": "Cynthia Koons"
},
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The actions have raised questions about why it took public pressure before the companies altered their programs.",
"body": null
},
{
"uri": "/2019/04/10/senators-call-for-investigation-into-pbms-spread-pricing/",
"title": "Senators call for investigation into PBM's spread pricing",
"byline": "Anna Edney and Robert Langreth",
"kicker": "News",
"prettyDate": "April 10, 2019",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/DrugPrices.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/robert-langreth/",
"name": "Robert Langreth"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The scrutiny is part of a wider inquiry by lawmakers into U.S. drug costs that has involved several Senate hearings.",
"body": null
},
{
"uri": "/2019/03/15/house-dems-investigating-junk-plan-health-insurers/",
"title": "House Dems investigating short-term health plan insurers",
"byline": "Anna Edney and Polly Mosendz",
"kicker": "News",
"prettyDate": "March 15, 2019",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/Capitol.jpg",
"width": "600",
"height": "338"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/polly-mosendz/",
"name": "Polly Mosendz"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Lawmakers want to know how companies market the plans, what percentage of applicants are denied coverage, and what brokers are paid. ",
"body": null
},
{
"uri": "/2019/02/01/trump-admin-proposes-ban-on-pharma-rebates/",
"title": "Trump administration proposes ban on pharma rebates",
"byline": "Anna Edney and Robert Langreth",
"kicker": "News",
"prettyDate": "February 01, 2019",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/prescription-pill-dollars-getty-e1530304375110.jpg",
"width": "620",
"height": "413"
},
"authors": [
{
"webUrl": "/author/profile/anna-edney/",
"name": "Anna Edney"
},
{
"webUrl": "/author/profile/robert-langreth/",
"name": "Robert Langreth"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The measure, released by HHS on Thursday, would roll back so-called safe-harbor protections for drug rebates.",
"body": null
},
{
"uri": "/2019/01/16/drugmakers-vs-trump-whats-next-for-the-showdown/",
"title": "Drugmakers vs. Trump: What's next for the showdown?",
"byline": "Kristen V Brown, Cynthia Koons, Anna Edney, and Riley Griffin",
"kicker": "Market Insights",
"prettyDate": "January 16, 2019",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/DrugCosts2.jpg",
"width": "600",
"height": "401"
},
"authors": [
{
"webUrl": "/author/profile/kristen-v-brown-cynthia-koons-anna-edney/",
"name": "Kristen V Brown, Cynthia Koons, Anna Edney,"
},
{
"webUrl": "/author/profile/riley-griffin/",
"name": "Riley Griffin"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "The Trump administration and Congress are gearing up for a renewed campaign to bring the companies to heel. Will it work?",
"body": null
}
]
}
}